Chargement en cours...

Euglycemic DKA in Patients on SGLT2 Inhibitor and Potentially Ketotic State

Background: With mounting evidence demonstrating improved cardiovascular and renal outcomes with the use of sodium-glucose cotransporter-2 (SGLT2) inhibitors, this class of newest antidiabetic agents is rapidly gaining favor. SGLT2 inhibition lowers the renal threshold for glucose excretion, resulti...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Endocr Soc
Auteurs principaux: Khalifa, Maram, Aftab, Hassaan, Kantorovich, Vitaly
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089681/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.779
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!